We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$4.3B
AUM Growth
-$283M
Cap. Flow
-$918M
Cap. Flow %
-21.37%
Top 10 Hldgs %
21.93%
Holding
769
New
128
Increased
67
Reduced
84
Closed
103
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRGW
451
DELISTED
Chain Bridge I Warrants
CBRGW
0
ONYXW
452
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
0
FHLTW
453
DELISTED
Future Health ESG Corp. Warrant
FHLTW
0
HCMAW
454
DELISTED
HCM Acquisition Corp Warrant
HCMAW
0
ARGUW
455
DELISTED
Argus Capital Corp. Warrant
ARGUW
0
MPRAW
456
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
0
NHICW
457
DELISTED
NewHold Investment Corp. II Warrant
NHICW
0
FIACW
458
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
0
HTPA.WS
459
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
0
WQGA.WS
460
DELISTED
World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WQGA.WS
0
RCFA.WS
461
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
0
XFINW
462
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
0
SPECW
463
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
0
TRAQ.WS
464
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
0
ACAQ.WS
465
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
0
PIPP.WS
466
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
0
AEVAW
467
DELISTED
Aeva Technologies Warrants
AEVAW
0
CLDI.WS
468
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
0
PNST.WS
469
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
0
TOACW
470
DELISTED
Talon 1 Acquisition Corp. Warrant
TOACW
0
BLEUW
471
DELISTED
bleuacacia ltd Warrants
BLEUW
0
BFAC.WS
472
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
0
ICPT
473
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$187K ﹤0.01%
11,500
-44,500
-79% -$697K
GVCIW
474
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
0
LGVCW
475
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
0

Similar funds

Highbridge Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Highbridge Capital Management held 769 positions worth $4.3B, down 6.2% from $4.58B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Highbridge Capital Management withdrew a net $918M in Q1 2022, closing 103 positions and reducing 84 holdings. Its most notable exit was Spartan Acquisition Corp. III, an estimated $26.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 32% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Highbridge Capital Management opened a new position in Integrated Rail and Resources Acquisition Corp. worth $19.2M.

  • Highbridge Capital Management's largest Q1 2022 buy was Integrated Rail and Resources Acquisition Corp.: 1,930,178 shares worth $19.2M.
  • Highbridge Capital Management added most to Amryt Pharma plc American Depositary Shares in Q1 2022, an estimated $37.9M increase.
  • Highbridge Capital Management's biggest Q1 2022 reduction was Hudson Executive Investment Corp. III Class A Common Stock, cutting an estimated $23M.
  • Highbridge Capital Management fully exited Spartan Acquisition Corp. III in Q1 2022, selling an estimated $26.9M.
  • Highbridge Capital Management's ten largest holdings make up 22% of its $4.3B portfolio in Q1 2022.
  • Highbridge Capital Management opened 128 new positions and closed 103 in Q1 2022.
  • Highbridge Capital Management's portfolio value fell 6.2% quarter-over-quarter to $4.3B.

Based on Highbridge Capital Management's 13F filing for Q1 2022, filed 11 May 2022.